Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen

Clinical trial NCT00069745 · COMPLETED

Trial details

NCT number: NCT00069745
Sponsor: Agennix
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer Hormone Refractory Prostate Cancer

Start date: 2003-09-01
Primary completion: 2006-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.